Provided by Tiger Trade Technology Pte. Ltd.

Avita Medical Ltd.

13.33
+0.28002.15%
Volume:347.91K
Turnover:4.55M
Market Cap:410.25M
PE:-9.25
High:13.40
Open:12.87
Low:12.53
Close:13.05
52wk High:13.50
52wk Low:3.22
Shares:30.78M
Float Shares:30.09M
Volume Ratio:0.88
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4413
EPS(LYR):-1.7439
ROE:-1746.27%
ROA:-41.56%
PB:-14.74
PE(LYR):-7.64

Loading ...

Analysts Are Neutral on These Healthcare Stocks: Cencora (COR), Avita Medical (RCEL)

TIPRANKS
·
Jul 22

AVITA to Announce Second Quarter 2026 Financial Results-rcel.o

Reuters
·
Jul 15

Avita Medical to Report Q2 2026 Financial Results After U.S. Market Close

Reuters
·
Jul 15

Statement of Cdis on Issue - Avh-rcel.o

Reuters
·
Jul 14

Notification Regarding Unquoted Securities - Avh-rcel.o

Reuters
·
Jul 13

Notification of Cessation of Securities - Avh-rcel.o

Reuters
·
Jul 08

Lake Street Reaffirms Their Buy Rating on Avita Medical (RCEL)

TIPRANKS
·
Jul 06

Notification of Cessation of Securities - Avh-rcel.o

Reuters
·
Jul 03

BTIG Sticks to Its Hold Rating for Avita Medical (RCEL)

TIPRANKS
·
Jun 24

AVITA Highlights first UK Clinical Experience with RECELL GO-RCEL.O

Reuters
·
Jun 19

Avita Medical (RCEL) Receives a Buy from TD Cowen

TIPRANKS
·
Jun 19

Avita Medical says UK case series supports RECELL GO use in burn surgery patients

Reuters
·
Jun 18

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

GlobeNewswire
·
Jun 18

Avita Medical director Woody Joseph Fralin acquires 5,200 common shares for $20,800

Reuters
·
Jun 11

Financial Report on Form 8-K Dated 5 June 2026-RCEL.O

Reuters
·
Jun 11

Change of Director's Interest Notice -SC JCC RM JSR MT CV JW-RCEL.O

Reuters
·
Jun 11

Notification regarding unquoted securities - AVH-RCEL.O

Reuters
·
Jun 11

Avita Medical director Woody Joseph Fralin acquires 10,000 common shares valued at $41,900

Reuters
·
Jun 10

Avita Medical director Woody Joseph Fralin acquires 10,000 common shares valued at $40,949.00

Reuters
·
Jun 06

Avita Medical shareholders approve non-executive director equity awards at annual meeting

Reuters
·
Jun 04